{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:36:54Z","timestamp":1783723014659,"version":"3.55.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Cryptococcus neoformans is a yeast that mainly affects immunocompromised individuals and causes meningoencephalitis depending on the immune status of the host. The present study aimed to validate the efficacy of selective serotonin reuptake inhibitors, fluoxetine hydrochloride (FLH) and paroxetine hydrochloride (PAH), alone and in combination with amphotericin B (AmB) against C. neoformans. Susceptibility tests were conducted using the broth microdilution method and synergistic effects of combining FLH and PAH with AmB were analyzed using the checkerboard assay. Effects of minimum inhibitory concentration (MIC) and synergistic concentration were evaluated in biofilms by quantifying the biomass, measuring the viability by counting the colony-forming units (CFU\/mL) and examining the size of the induced capsules. Cryptococcus neoformans was susceptible to FLH and PAH and the synergistic effect of FLH and PAH in combination with AmB reduced the MIC of AmB by up to 8-fold. The isolated substances and combination with AmB were able to reduce biofilm biomass and biofilm viability. In addition, FLH and PAH alone or in combination with AmB significantly decreased the size of the yeast capsules. Collectively, our results indicate the use of FLH and PAH as a promising prototype for the development of anti-cryptococcal drugs.<\/jats:p>","DOI":"10.1093\/femspd\/ftab001","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T21:38:09Z","timestamp":1609882689000},"source":"Crossref","is-referenced-by-count":16,"title":["<i>In vitro<\/i> synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against <i>Cryptococcus neoformans<\/i>"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-3348","authenticated-orcid":false,"given":"Tha\u00eds Cristine","family":"Pereira","sequence":"first","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP), Av. Engenheiro Francisco Jos\u00e9 Longo, 777 S\u00e3o Jos\u00e9 dos Campos, S\u00e3o Paulo 12245-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-5528","authenticated-orcid":false,"given":"Raquel Teles","family":"de\u00a0Menezes","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP), Av. Engenheiro Francisco Jos\u00e9 Longo, 777 S\u00e3o Jos\u00e9 dos Campos, S\u00e3o Paulo 12245-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5760-4209","authenticated-orcid":false,"given":"Haroldo Cesar","family":"de\u00a0Oliveira","sequence":"additional","affiliation":[{"name":"Instituto Carlos Chagas, Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rua Prof. Algacyr Munhoz Mader, 3775 Curitiba, PR 81350-010, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-9551","authenticated-orcid":false,"given":"Luciane Dias","family":"de\u00a0Oliveira","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP), Av. Engenheiro Francisco Jos\u00e9 Longo, 777 S\u00e3o Jos\u00e9 dos Campos, S\u00e3o Paulo 12245-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0178-6653","authenticated-orcid":false,"given":"Liliana","family":"Scorzoni","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP), Av. Engenheiro Francisco Jos\u00e9 Longo, 777 S\u00e3o Jos\u00e9 dos Campos, S\u00e3o Paulo 12245-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"2021022316381286300_bib1","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1590\/s1678-9946201759013","article-title":"The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital","volume":"59","author":"Aguiar","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2021022316381286300_bib2","doi-asserted-by":"crossref","first-page":"e180040","DOI":"10.1590\/0074-02760180040","article-title":"Peeling the onion: the outer layers of Cryptococcus neoformans","volume":"113","author":"Agustinho","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2021022316381286300_bib3","first-page":"71.e571","article-title":"EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents","volume":"22","author":"Arendrup","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2021022316381286300_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fmicb.2016.00290","article-title":"Virulence of Cryptococcus sp. biofilms in vitro and in vivo using Galleria mellonella as an alternative model","volume":"7","author":"Benaducci","year":"2016","journal-title":"Front Microbiol"},{"key":"2021022316381286300_bib5","first-page":"424","article-title":"Clinical use of systemic antifungal agents","volume":"7","author":"Benson","year":"1988","journal-title":"Clin Pharm"},{"key":"2021022316381286300_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/myc.12801","article-title":"Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections","volume":"61","author":"Borba","year":"2018","journal-title":"Mycoses"},{"key":"2021022316381286300_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.34.2.183","article-title":"Amphotericin B: current understanding of mechanisms of action","volume":"34","author":"Brajtburg","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bjid.2015.06.001","article-title":"Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species","volume":"19","author":"Brilhante","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"2021022316381286300_bib9","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"2021022316381286300_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/9781555818241","volume-title":"Cryptococcus neoformans","author":"Casadevall","year":"1998"},{"key":"2021022316381286300_bib10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI42949","article-title":"Cryptococci at the brain gate: break and enter or use a Trojan horse?","volume":"120","author":"Casadevall","year":"2010","journal-title":"J Clin Invest"},{"key":"2021022316381286300_bib12","doi-asserted-by":"crossref","first-page":"e86499","DOI":"10.1371\/journal.pone.0086499","article-title":"ASDCD: antifungal synergistic drug combination database","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"2021022316381286300_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800261-2.00001-3","article-title":"The tools for virulence of Cryptococcus neoformans","volume":"87","author":"Coelho","year":"2014","journal-title":"Adv Appl Microbiol"},{"key":"2021022316381286300_bib14","doi-asserted-by":"crossref","first-page":"e0167903","DOI":"10.1371\/journal.pone.0167903","article-title":"In vitro antifungal activity of sertraline and synergistic effects in combination with antifungal drugs against planktonic forms and biofilms of clinical Trichosporon asahii isolates","volume":"11","author":"Cong","year":"2016","journal-title":"PLoS One"},{"key":"2021022316381286300_bib15","doi-asserted-by":"crossref","first-page":"105023","DOI":"10.1016\/j.actatropica.2019.05.014","article-title":"Cryptococcosis in the Amazon: a current overview and future perspectives","volume":"197","author":"Corr\u00eaa\u00a0Pinheiro","year":"2019","journal-title":"Acta Trop"},{"key":"2021022316381286300_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.micpath.2017.04.008","article-title":"In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates","volume":"107","author":"Costa\u00a0Silva","year":"2017","journal-title":"Microb Pathog"},{"key":"2021022316381286300_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4155\/fmc.13.189","article-title":"Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms","volume":"6","author":"Delattin","year":"2014","journal-title":"Future Med Chem"},{"key":"2021022316381286300_bib17","first-page":"e00286","article-title":"Fenbendazole controls in vitro growth, virulence potential, and animal infection in the Cryptococcus model","volume":"64","author":"de\u00a0Oliveira","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib19","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1128\/IAI.70.9.4762-4771.2002","article-title":"Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cells","volume":"70","author":"Ellerbroek","year":"2002","journal-title":"Infect Immun"},{"key":"2021022316381286300_bib21","doi-asserted-by":"crossref","first-page":"e1002585","DOI":"10.1371\/journal.ppat.1002585","article-title":"Fungal biofilms","volume":"8","author":"Fanning","year":"2012","journal-title":"PLoS Pathog"},{"key":"2021022316381286300_bib22","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1099\/00221287-147-8-2355","article-title":"Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection","volume":"147","author":"Feldmesser","year":"2001","journal-title":"Microbiology"},{"key":"2021022316381286300_bib24","first-page":"57171","article-title":"Size matters: measurement of capsule diameter in Cryptococcus neoformans","volume":"132","author":"Guess","year":"2018","journal-title":"J Vis Exp"},{"key":"2021022316381286300_bib23","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/AAC.03046-15","article-title":"The synergistic effect of azoles and fluoxetine against resistant Candida albicans is attributed to attenuating fungal virulence","volume":"60","author":"Gu","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s15010-018-1152-2","article-title":"Neuroinfections caused by fungi","volume":"46","author":"G\u00f3ralska","year":"2018","journal-title":"Infection"},{"key":"2021022316381286300_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"2021022316381286300_bib27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3201\/eid1910.130441","article-title":"Cryptococcus gattii infections in multiple states outside the US Pacific Northwest","volume":"19","author":"Harris","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2021022316381286300_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/08927014.2020.1777401","article-title":"In vitroandin vivo evaluation of the antifungal activity of fluoxetine combined with antifungals against Candida albicans biofilms and oral candidiasis","volume":"36","author":"Jiang","year":"2020","journal-title":"Biofouling"},{"key":"2021022316381286300_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2017.00535","article-title":"The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcus neoformans","volume":"8","author":"Joffe","year":"2017","journal-title":"Front Microbiol"},{"key":"2021022316381286300_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1513\/pats.200510-110JH","article-title":"Fungal infections","volume":"3","author":"Kauffman","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2021022316381286300_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"2021022316381286300_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-007-6142-8","article-title":"Non-neoformans cryptococcal infections: a systematic review","volume":"35","author":"Khawcharoenporn","year":"2007","journal-title":"Infection"},{"key":"2021022316381286300_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.12.009","article-title":"Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery","volume":"43","author":"Liu","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"2021022316381286300_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12281-013-0165-7","article-title":"Macrophage Cryptococcus interactions: an update","volume":"8","author":"Mansour","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"2021022316381286300_bib37","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1128\/AEM.02506-06","article-title":"Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light","volume":"73","author":"Martinez","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"2021022316381286300_bib35","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1128\/IAI.73.10.6350-6362.2005","article-title":"Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy","volume":"73","author":"Martinez","year":"2005","journal-title":"Infect Immun"},{"key":"2021022316381286300_bib36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/AAC.50.3.1021-1033.2006","article-title":"Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro","volume":"50","author":"Martinez","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pds.1355","article-title":"Trends in antidepressant overdoses","volume":"16","author":"McKenzie","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021022316381286300_bib39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00002030-199904160-00005","article-title":"Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans","volume":"13","author":"Monari","year":"1999","journal-title":"AIDS"},{"key":"2021022316381286300_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1099\/jmm.0.47247-0","article-title":"Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus","volume":"56","author":"Mowat","year":"2007","journal-title":"J Med Microbiol"},{"key":"2021022316381286300_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mmcr.2017.11.004","article-title":"Emerging fluconazole resistance: implications for the management of cryptococcal meningitis","volume":"19","author":"Mpoza","year":"2018","journal-title":"Med Mycol Case Rep"},{"key":"2021022316381286300_bib42","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/B978-0-7020-4088-7.00095-X","article-title":"Fungal infections of the central nervous system","volume":"121","author":"Murthy","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"2021022316381286300_bib43","first-page":"99","article-title":"Effects of sertraline hydrochloride and fluconazole combinations on Cryptococcus neoformans and Cryptococcus gattii","volume-title":"Mycology","author":"Nayak","year":"2010"},{"key":"2021022316381286300_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/AAC.43.2.233","article-title":"Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations","volume":"43","author":"Nosanchuk","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"key":"2021022316381286300_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2021022316381286300_bib47","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1128\/AAC.02623-13","article-title":"Anti-Candida activity of fluoxetine alone and combined with fluconazole: a synergistic action against fluconazole-resistant strains","volume":"58","author":"Oliveira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","article-title":"Drug repurposing: far beyond new targets for old drugs","volume":"14","author":"Oprea","year":"2012","journal-title":"AAPS J"},{"key":"2021022316381286300_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1054\/drup.1999.0090","article-title":"Drug resistance in Cryptococcus neoformans","volume":"2","author":"Perfect","year":"1999","journal-title":"Drug Resist Updat"},{"key":"2021022316381286300_bib50","doi-asserted-by":"crossref","first-page":"e00103","DOI":"10.1128\/mBio.00103-11","article-title":"Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host","volume":"2","author":"Price","year":"2011","journal-title":"mBio"},{"key":"2021022316381286300_bib51","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021022316381286300_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-407673-0.00002-3","article-title":"The clinical importance of fungal biofilms","volume":"84","author":"Ramage","year":"2013","journal-title":"Adv Appl Microbiol"},{"key":"2021022316381286300_bib53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1473-3099(19)30127-6","article-title":"Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial","volume":"19","author":"Rhein","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021022316381286300_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/EC.00318-06","article-title":"Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport","volume":"6","author":"Rodrigues","year":"2007","journal-title":"Eukaryot Cell"},{"key":"2021022316381286300_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12223-016-0449-8","article-title":"In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii","volume":"61","author":"Rossato","year":"2016","journal-title":"Folia Microbiol (Praha)"},{"key":"2021022316381286300_bib1_569_1610985764122","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","article-title":"ImageJ2: ImageJ for the next generation of scientific image data","volume":"18","author":"Rueden","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"2021022316381286300_bib56","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/AAC.06098-11","article-title":"Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii","volume":"56","author":"Santos","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front Microbiol"},{"key":"2021022316381286300_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijantimicag.2007.07.019","article-title":"Recent advances and challenges in the treatment of invasive fungal infections","volume":"30","author":"Shao","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"2021022316381286300_bib59","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1128\/AAC.01299-15","article-title":"Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021022316381286300_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"key":"2021022316381286300_bib61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijantimicag.2017.03.015","article-title":"Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence","volume":"50","author":"Sun","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2021022316381286300_bib62","first-page":"542","article-title":"Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog","volume":"17","author":"Tremaine","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"2021022316381286300_bib63","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/mmy\/myv109","article-title":"Activity of sertraline against Cryptococcus neoformans: in vitroandin vivoassays","volume":"54","author":"Trevi\u00f1o-Rangel","year":"2016","journal-title":"Med Mycol"},{"key":"2021022316381286300_bib64","doi-asserted-by":"crossref","first-page":"e4761","DOI":"10.7717\/peerj.4761","article-title":"Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis","volume":"6","author":"Truong","year":"2018","journal-title":"PeerJ"},{"key":"2021022316381286300_bib65","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2217\/fmb.13.84","article-title":"Elucidating the immunological function of the Cryptococcus neoformans capsule","volume":"8","author":"Vecchiarelli","year":"2013","journal-title":"Future Microbiol"},{"key":"2021022316381286300_bib66","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/tmi.12790","article-title":"Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in S\u00e3o Paulo, Brazil","volume":"21","author":"Vidal","year":"2016","journal-title":"Trop Med Int Health"},{"key":"2021022316381286300_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jiac.2019.10.001","article-title":"Evaluation of the expanding spectrum of sertraline against uncommon fungal pathogens","volume":"26","author":"Villanueva-Lozano","year":"2020","journal-title":"J Infect Chemother"},{"key":"2021022316381286300_bib68","first-page":"373","article-title":"Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study","volume":"18","author":"Walsh","year":"1986","journal-title":"Neurosurgery"},{"key":"2021022316381286300_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1251\/bpo68","article-title":"Experimental modulation of capsule size in Cryptococcus neoformans","volume":"6","author":"Zaragoza","year":"2004","journal-title":"Biol Proced Online"},{"key":"2021022316381286300_bib70","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1462-5822.2008.01186.x","article-title":"Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival","volume":"10","author":"Zaragoza","year":"2008","journal-title":"Cell Microbiol"},{"key":"2021022316381286300_bib71","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/eji.200323848","article-title":"The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions","volume":"33","author":"Zaragoza","year":"2003","journal-title":"Eur J Immunol"},{"key":"2021022316381286300_bib72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2958.2005.04928.x","article-title":"The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding","volume":"59","author":"Zaragoza","year":"2006","journal-title":"Mol Microbiol"},{"key":"2021022316381286300_bib73","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/advance-article-pdf\/doi\/10.1093\/femspd\/ftab001\/35544416\/ftab001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/79\/2\/ftab001\/36343570\/ftab001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/79\/2\/ftab001\/36343570\/ftab001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T17:12:07Z","timestamp":1614100327000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/ftab001\/6070654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,19]]}},"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftab001","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2021,1,8]]},"article-number":"ftab001"}}